|
|
|
||||||||||
Associate Clinical Professor, School of Pharmacy, University of Connecticut, Storrs, CT; Clinical Psychopharmacology Consultant, Institute of Living, Hartford, CT
Reprints: Dr. Caley, Institute of Living, Burlingame Research Center, 200 Retreat Ave., Hartford, CT 06106, fax 860/545-7066, c.caley{at}uconn.edu
Abstract
Bipolar disorder is a brain illness with complexities in its composition and treatment. Results from the National Comorbidity Survey Replication study estimate the lifetime prevalence of bipolar spectrum illnesses to be 4.5%. These patients were also reported to have their illnesses frequently treated suboptimally and to be at risk of suffering extensive disability. Pharmacists are in a key position to deliver important pharmacy care services to patients who have bipolar disorder and receive treatments in need of close monitoring. Described here are the results of this study and opportunities for pharmacists to support this important patient population.
Key Words: bipolar disorder, depression, mania, mixed, pharmacist, pharmacotherapy, subsyndromal
Published Online, October 6, 2009. www.theannals.com, DOI 10.1345/aph.1M432